Document Detail


Relationship between oral amiodarone and inappropriate therapy from an implantable cardioverter defibrillator.
MedLine Citation:
PMID:  20484827     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: This study evaluated the efficacy of amiodarone for avoiding inappropriate therapies by implantable cardioverter defibrillators (ICDs).
METHODS AND RESULTS: A total of 232 patients with structural heart disease (58+/-13 years; 78% males) who underwent an initial ICD implantation were retrospectively investigated to compare baseline characteristics and event rates of inappropriate ICD therapy delivery between patients with oral amiodarone therapy (amiodarone group, n=116) and those without (non-amiodarone group, n=116). During a mean follow-up of 29+/-21 months, inappropriate therapies occurred less frequently in the amiodarone group than in the non-amiodarone group (12% vs 27%, P=0.0068). As a cause of inappropriate ICD therapy, only atrial fibrillation (AF) significantly differed between the groups (3% vs 12%, P=0.01). The results of multivariate logistic regression analysis showed that amiodarone therapy (odds ratio (OR) 0.38, 95% confidence interval (CI) 0.19-0.77, P=0.0073) and no history of spontaneous AF (OR 0.27, 95%CI 0.13-0.57, P=0.0007) were independent predictors of a lower risk of inappropriate ICD therapy.
CONCLUSIONS: In the present group of ICD patients with structural heart disease, inappropriate therapy delivery occurred predominantly in those with spontaneous AF and/or without amiodarone.
Authors:
Takayuki Nagai; Kazuhiro Satomi; Takashi Noda; Hideo Okamura; Yuko Yamada; Wataru Shimizu; Kazuhiro Suyama; Naohiko Aihara; Shiro Kamakura; Takashi Kurita
Related Documents :
8459077 - Effects of oral theophylline on sick sinus syndrome.
11216977 - Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatmen...
9116967 - Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard ...
6362387 - A controlled trial of propafenone for treatment of frequent and repetitive ventricular ...
4078917 - Thyrotoxicosis developing within one year following migration to the united states.
21666527 - Prospective longitudinal evaluation of lung function during the first year of life afte...
Publication Detail:
Type:  Journal Article     Date:  2010-05-18
Journal Detail:
Title:  Circulation journal : official journal of the Japanese Circulation Society     Volume:  74     ISSN:  1347-4820     ISO Abbreviation:  Circ. J.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-06-30     Completed Date:  2010-10-19     Revised Date:  2011-02-18    
Medline Journal Info:
Nlm Unique ID:  101137683     Medline TA:  Circ J     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  1302-7     Citation Subset:  IM    
Affiliation:
Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Amiodarone / administration & dosage*
Atrial Fibrillation
Defibrillators, Implantable / adverse effects*
Female
Heart Diseases / therapy
Humans
Male
Middle Aged
Prognosis
Retrospective Studies
Risk Factors
Treatment Failure
Chemical
Reg. No./Substance:
1951-25-3/Amiodarone
Comments/Corrections
Comment In:
Circ J. 2010 Jul;74(7):1290-1   [PMID:  20558884 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Single-site Bachmann's bundle pacing is beneficial while coronary sinus pacing results in echocardio...
Next Document:  Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral a...